A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

Discover why Cartesian Therapeutics, Inc. earns a Buy rating with strong CAR-T pipeline progress and market growth in ...

Last week, Canada officially lost its measles elimination status, which it held for nearly 30 years — a shameful consequence of falling childhood vaccination rates.

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and ...

Pennsylvania’s short-term politics threaten its biotech future, driving innovation and opportunity to rival states.

The study was published in Nature Biotechnology last month and marks a shift in scientists’ understanding of how to ...

After getting vaccinated against COVID, Kirsch became convinced that the shot was unsafe and began campaigning against it. He ...

When your body's immune cells attack you instead of protecting you, today's treatments tamp down the friendly fire but they ...

The fate of CureVac hangs in the balance as shareholders approach a pivotal deadline that will determine whether the Tübingen-based biotech firm maintains it ...

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...